Indaptus Therapeutics Inc. (INDP) Live Share Price, Invest From India

Indaptus Therapeutics Inc. Stock Performance

as on July 21, 2026 at 2:15 pm IST

Day's Low
Day's High
$2.42
Day's Price Range
$2.53
$2.46
1.63%
Downside
2.85%
Upside
52 Week's Low
52 Week's High
$0.92
52-Week Price Range
$12.03
$2.46
62.60%
Downside
388.96%
Upside

Indaptus Therapeutics Inc. share price movements today

Previous Close: $2.53
Open: $2.42
Volume: 148.9K
Day's Low - High: $2.42 - $2.53
52 Week Low - High: $0.92 - $12.03

Indaptus Therapeutics Inc. Historical Returns

1 Month Return: -36.92 %
3 Month Return: -30.51 %
1 Year Return: -77.43 %
3 Year Return: -95.3 %
5 Year Return: -83.01 %

Indaptus Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Indaptus Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$337.1M

EPS (TTM)

-6.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-19.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-931.79%

Indaptus Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indaptus Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Indaptus Therapeutics Inc.	BUY	$337.1M	-83.01%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.6B	496.73%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.3B	144.82%	28.82	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.9B	15.15%	16.53	29.65%	0.53%

Stock Returns calculator for Indaptus Therapeutics Inc. Stock including INR - Dollar returns

The Indaptus Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Indaptus Therapeutics Inc. investment value today

Current value as on today

₹25,253

Returns

-₹74,747

(-74.75%)

Returns from Indaptus Therapeutics Inc. Stock

-₹77,431 (-77.43%)

Dollar Impact

₹2,684 (+2.68%)

Analyst Recommendation on Indaptus Therapeutics Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Indaptus Therapeutics Inc.. Average target price of $10

Indaptus Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Indaptus Therapeutics Inc..

What analysts predicted

75.4%UPSIDE

Target Price

$10

Current Price

$2.46

Analyzed by

8 Analysts

Target

$10.00

Indaptus Therapeutics Inc. target price $10, a slight upside of 75.4% compared to current price of $2.46. According to 8 analysts rating.

Indian Investors' Interest in Indaptus Therapeutics Inc. Stock

Search interest for Indaptus Therapeutics Inc. Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.

Time period: June 21, 2026 to July 21, 2026

Change:-51% versus previous 30 day period

Indaptus Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	-	-	0	-	-	-	-	-
Operating Income	-4	-3	-4	-3	-4	-4	-4	-2	-8	-2
EBITDA	-4	-3	-4	-3	-4	-4	-5	-2	-8	-2
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	-	-	-	-	-	-	-	-
Income Before Tax	-4	-3	-4	-3	-4	-4	-5	-2	-8	-2
Income Tax Expense	-4	0	-	-	0	-	-	-	-	-
Net Income	-4	-3	-4	-3	-4	-4	-5	-2	-8	-2
Net Profit Margin	-207613.07%	0.00%	0.00%	0.00%	-281023.61%	0.00%	0.00%	0.00%	0.00%	0.00%

Indaptus Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-
Operating Income	-3	-7	-14	-16	-15	-19
EBITDA	-3	-7	-14	-15	-15	-20
Interest Expense	0	0	0	-	-	-
Depreciation	0	0	0	0	0	-
Income Before Tax	-3	-7	-14	-15	-15	-20
Income Tax Expense	0	0	0	-16	-	-
Net Income	-3	-7	-14	-15	-15	-20
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Indaptus Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-4	-3	-4	-4	-5	-2	-8	-2
Operating Cash Flow	-3	-2	-2	-3	-5	-4	-3	-3	-7
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	2	1	3	6	2	5	-
Change in Cash	-3	-2	0	-1	-1	2	0	2	-7

Indaptus Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-28	-43	-47	-3	-7	-14	-15	-15	-20
Operating Cash Flow	-22	-39	-29	-3	-11	-13	-13	-12	-14
Investing Cash Flow	-4	-9	-3	0	0	-16	17	-	-
Financing Cash Flow	63	35	2	1	48	0	-	4	17
Change in Cash	36	-14	-29	-2	37	-29	3	-7	2

Global Institutional Holdings in Indaptus Therapeutics Inc.

Funds	Holdings
Geode Capital Management, LLC	0.02%
Investment House LLC	0%
SBI Securities Co Ltd	0%
Strategy Asset Managers LLC	0%
Pine Valley Investments Ltd Liability Co	0%

See all

Insights on Indaptus Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 369.5% return, outperforming this stock by 446.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.9% return, outperforming this stock by 669.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, INDP stock has moved down by -36.9%

About Indaptus Therapeutics Inc.

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.

Organisation	Indaptus Therapeutics Inc.
Headquarters	Three Columbus Circle, New York, NY, United States, 10019
Industry	Biotechnology
CEO	Mr. Junyi Dai
E-voting on shares	Click here to vote

Key Management of Indaptus Therapeutics Inc.

Name	Title
Mr. Junyi Dai	CEO & Chairman
Mr. Yu Ding	Chief Financial Officer

FAQs

What is Indaptus Therapeutics Inc. share price today?

Indaptus Therapeutics Inc. share price today is $2.46 as on July 21, 2026 at 8:45 am IST at the close of the market. Indaptus Therapeutics Inc. share today touched a day high of $2.53 and a low of $2.42.

What is the 52 week high and 52 week low for Indaptus Therapeutics Inc. share?

Indaptus Therapeutics Inc. share touched a 52 week high of $12.03 on July 21, 2025 and a 52 week low of $0.92 on May 22, 2026. Indaptus Therapeutics Inc. stock price today i.e. July 21, 2026 at 8:45 am IST is closed at $2.46,which is 79.55% down from its 52 week high and 167.39% up from its 52 week low.

What is Indaptus Therapeutics Inc.'s market capitalisation today?

Indaptus Therapeutics Inc. market capitalisation is $0.00T as on July 21, 2026 at 8:45 am IST.

How to invest in Indaptus Therapeutics Inc. Stock (INDP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Indaptus Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Inc. Shares that will get you 0.6098 shares as per Indaptus Therapeutics Inc. share price of $2.46 per share as on July 21, 2026 at 8:45 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Inc. Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics Inc. (INDP) shares with as little as ₹96.445 or $1 (as of July 21, 2026 at 1:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹964.45 in Indaptus Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 21, 2026 at 1:45 pm IST). Based on Indaptus Therapeutics Inc. share’s latest price of $2.46 as on July 21, 2026 at 8:45 am IST, you will get 4.0650 shares of Indaptus Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics Inc. has given to Indian investors in the last 5 years?

Indaptus Therapeutics Inc. stock has given -83.01% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?